Testing effectiveness (Phase 2)Study completedNCT04036968What this trial is testingEnhancing Medication-based Analgesia in Humans- STUDY 2Who this might be right forPainCannabisOpioid Use Johns Hopkins University 31
Testing effectiveness (Phase 2)UnknownNCT05005468What this trial is testingA Phase II Trial of Camrelizumab Combined With Famitinib for Adjuvant Treatment of Stage II-IIIA NSCLC.Who this might be right forNSCLC Shanghai Chest Hospital 61
Testing effectiveness (Phase 2)Study completedNCT00006450What this trial is testingPhenylbutyrate to Treat Children With Progressive or Recurrent Brain TumorsWho this might be right forBrain Tumor National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Looking for participantsNCT06561360What this trial is testingVemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)Who this might be right forHairy Cell Leukemia Memorial Sloan Kettering Cancer Center 86
Early research (Phase 1)Study completedNCT02544880What this trial is testingPDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCCWho this might be right forHead and Neck Squamous Cell CarcinomaHead and Neck Cancer Donald T. Weed, MD, FACS 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07040280What this trial is testingTesting the Effect of Sulforaphane, a Compound Naturally Found in Cruciferous Vegetables, on Preventing Melanoma in Patients With a Prior History of MelanomaWho this might be right forMelanoma Eastern Cooperative Oncology Group 120
Testing effectiveness (Phase 2)UnknownNCT00003327What this trial is testingPaclitaxel in Treating Patients With Recurrent or Refractory Head and Neck CancerWho this might be right forHead and Neck Cancer Theradex 60
Testing effectiveness (Phase 2)UnknownNCT04296786What this trial is testingSintilimab Plus Chidamide in the Treatment of Relapsed and Refractory Cutaneous T-cell Lymphoma: a Multicenter Phase II StudyWho this might be right forCutaneous T-cell Lymphoma Peking Union Medical College Hospital 52
Testing effectiveness (Phase 2)Study completedNCT01471470What this trial is testingEfficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric CancerWho this might be right forAdvanced Gastric Cancer Asan Medical Center 31
Testing effectiveness (Phase 2)WithdrawnNCT00005969What this trial is testingLiposomal Tretinoin in Treating Patients With Recurrent or Refractory Hodgkin's DiseaseWho this might be right forLymphoma M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00511069What this trial is testingVelcade (Bortezomib - PS341) in the Treatment of Patients Over 18 Years With Ph+ LeukemiaWho this might be right forLeukemia University of Bologna 3
Testing effectiveness (Phase 2)Study completedNCT01259869What this trial is testingPX-866 in Patients With Glioblastoma Multiforme at Time of First Relapse or ProgressionWho this might be right forGlioblastoma NCIC Clinical Trials Group 34
Not applicableLooking for participantsNCT05930483What this trial is testingRemotely Delivered, Community-Aligned Weight Loss Interventions Among Breast Cancer Survivors, ¡Vida! TrialWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8 Fred Hutchinson Cancer Center 640
Testing effectiveness (Phase 2)UnknownNCT06282783What this trial is testingStudying Topiramate for Re-Activating the HIV-1 ReservoirWho this might be right forHIV-1-infectionHivHIV Infections+1 more Erasmus Medical Center 12
Testing effectiveness (Phase 2)Ended earlyNCT02759315What this trial is testingEfficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)Who this might be right forHepatitis C, Chronic Merck Sharp & Dohme LLC 160
Testing effectiveness (Phase 2)WithdrawnNCT03623776What this trial is testingNeoadjuvant JS001, or JS001 in Combination With Pemetrexed and Carboplatin in Resectable NSCLC.Who this might be right forEfficacy and Safety Sun Yat-sen University
Testing effectiveness (Phase 2)Ended earlyNCT02748889What this trial is testingCarboplatin Plus Etoposide With or Without MPDL3280A in Untreated Extensive Stage Small Cell Lung CancerWho this might be right forSmall Cell Lung Cancer ( SCLC ) Giuseppe Giaccone 1
Testing effectiveness (Phase 2)UnknownNCT01283789What this trial is testingLapatinib and RAD-001 for HER2 Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer University of Kansas Medical Center 23
Large-scale testing (Phase 3)WithdrawnNCT00729768What this trial is testingEvaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal TransplantationWho this might be right forKidney Transplantation Genentech, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT01689974What this trial is testingPhase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic MelanomaWho this might be right forMetastatic Melanoma NYU Langone Health 10